Lupin ropes in Jeffrey Kindler, Alfonso Zulueta as Independent Directors Ruchika Sharma9 May 2024 12:02 PM ISTMumbai: Pharma major Lupin Limited has announced the appointment of Jeffrey Kindler and Alfonso "Chito" Zulueta as Independent Directors to its...
Lupin net profit surges 52 percent at Rs 359 crore in Q4 Ruchika Sharma8 May 2024 3:16 PM ISTNew Delhi: Pharmaceutical giant Lupin has announced a notable 52 percent surge in consolidated net profit, reaching Rs 359 crore in the March...
Lupin bags USFDA nod for Travoprost Ophthalmic Solution Ruchika Sharma7 May 2024 11:43 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Lupin bags USFDA approval for Loteprednol Etabonate Ophthalmic Suspension Ruchika Sharma26 April 2024 11:40 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
USFDA issues EIR for Lupin Aurangabad facility Ruchika Sharma24 April 2024 11:46 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Lupin unveils Mirabegron ER tablets in US Ruchika Sharma22 April 2024 12:09 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after...
Lupin Gets CDSCO Panel Nod to Study Glycopyrronium Bromide, Vilanterol Trifenatate powder for inhalation in capsule Dr. Divya Colin13 April 2024 5:30 PM ISTNew Delhi: Reviewing the Phase IV clinical trial protocol of Lupin's pulmonary FDC (Fixed Dose Combination) Glycopyrronium Bromide plus Vilanterol...
USFDA concludes inspection of Lupin Dabhasa facility with no observations Ruchika Sharma13 April 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...
Glenmark, Lupin and 1 other recall products in US over manufacturing issues Ruchika Sharma11 April 2024 3:02 PM ISTNew Delhi: Glenmark, Lupin, and Natco Pharma, key players in the generic drug industry, are recalling products in the American market due to...
Lupin unveils first generic version of Oracea in US Ruchika Sharma10 April 2024 11:15 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of first generic version of Oracea (Doxycycline Capsules, 40 mg), in the...
USFDA approves Lupin Valbenazine Capsules Ruchika Sharma9 April 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
